Conditions: Symptomatic Gastroesophageal Reflux Disease (sGERD)
Keywords: Gastroesophageal Reflux Disease GERD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 305
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the efficacy, safety and tolerability of rabeprazole extended release (ER) 50 mg with placebo in subjects with symptomatic gastroesophageal reflux disease (sGERD).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: rabeprazole sodium intervention 2: Placebo
Intervention descriptions: intervention 1: One rabeprazole extended release (ER) 50 mg capsule daily; rescue medication will be provided to subjects to take as needed. intervention 2: One rabeprazole placebo capsule daily; rescue medication will be provided to subjects to take as needed.

Protocol document: